IGC Pharma (IGC) Revenue (2010 - 2025)
IGC Pharma (IGC) reported Revenue of $191000.0 for Q3 2025, down 53.64% year-over-year from $412000.0 in Q3 2024, and down 41.77% quarter-over-quarter from $328000.0 in Q2 2025.
IGC Pharma (IGC) Revenue (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has 16 years of Revenue data on file, last reported at $191000.0 in Q3 2025.
- Revenue for Q3 2025 came in at $191000.0, down 53.64% year-over-year; the trailing twelve-month figure through Sep 2025 was $1.1 million (down 6.51% YoY), and the FY2026 annual result was $317000.0, down 75.06% from the prior year.
- Revenue fell to $191000.0 in Q3 2025 per IGC's latest filing, from $328000.0 in the prior quarter.
- Over five years, Revenue peaked at $555000.0 in Q2 2023 and troughed at $56000.0 in Q3 2021.
- A 5-year average of $238157.9 and a median of $212000.0 in 2022 frame the typical range for Revenue.
- The sharpest annual moves came in 2021 and 2022: Revenue plunged 86.82% in 2021, then soared 260.71% in 2022.
- A 5-year view of Revenue shows it stood at $142000.0 in 2021, then surged by 133.8% to $332000.0 in 2022, then sank by 38.55% to $204000.0 in 2023, then increased by 25.98% to $257000.0 in 2024, then slipped by 25.68% to $191000.0 in 2025.
- Business Quant data shows IGC's Revenue at $191000.0 in Q3 2025, $328000.0 in Q2 2025, and $330000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 191,000.00 |
| Jun 30, 2025 | 328,000.00 |
| Mar 31, 2025 | 330,000.00 |
| Dec 31, 2024 | 257,000.00 |
| Sep 30, 2024 | 412,000.00 |
| Jun 30, 2024 | 272,000.00 |
| Mar 31, 2024 | 295,000.00 |
| Dec 31, 2023 | 204,000.00 |
| Sep 30, 2023 | 291,000.00 |
| Jun 30, 2023 | 555,000.00 |
| Mar 31, 2023 | 166,000.00 |
| Dec 31, 2022 | 332,000.00 |
| Sep 30, 2022 | 202,000.00 |
| Jun 30, 2022 | 212,000.00 |
| Mar 31, 2022 | 122,000.00 |
| Dec 31, 2021 | 142,000.00 |
| Sep 30, 2021 | 56,000.00 |
| Jun 30, 2021 | 77,000.00 |
| Mar 31, 2021 | 81,000.00 |
| Dec 31, 2020 | 108,000.00 |